This study is completed in Russia. It is testing prospekta for ADHD.
ADHDDrugFrom 7 Years to 12 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Efficacy and Safety of Prospekta may be useful for children experiencing ADHD.
What would participation involve?
Participants may receive Efficacy and Safety of Prospekta, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Russia.
Who is it mainly for?
This study appears to be mainly for children with ADHD. Because it involves minors, a parent or guardian may need to be involved.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: November 20, 2020
Recruitment status
Completed
Enrollment listed in the registry
363
Sponsor
Materia Medica Holding
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Russia
Age range
From 7 Years to 12 Years
Official registry ID
NCT04569357
Official title
Multicenter Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT04569357. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Russia · 31 sites
Hospital "Russian Railways - Medicine" of the city of Bryansk
Bryansk
Site status: Not listed — confirm with the team
Regional Clinical Specialized Psychoneurological Hospital # 1/Children's dispensary department
Chelyabinsk
Site status: Not listed — confirm with the team
Engels Psychiatric Hospital
Engel's
Site status: Not listed — confirm with the team
Kazan State Medical University/Department of Neurology, Neurosurgery and Medical Genetics
Kazan'
Site status: Not listed — confirm with the team
Children's Republican Clinical Hospital/Neurological department for the treatment of patients with CNS lesions with mental disorders
Kazan'
Site status: Not listed — confirm with the team
Specialized Clinical Psychiatric Hospital # 1/Dispensary department
Krasnodar
Site status: Not listed — confirm with the team
Russian National Research Medical University named after N.I. Pirogov/Department of Neurology, Neurosurgery and Medical Genetics, Faculty of Pediatrics
Moscow
Site status: Not listed — confirm with the team
Research and Practical Center of Pediatric Psychoneurology of Moscow City Health Department/Consultative and polyclinic department
Moscow
Site status: Not listed — confirm with the team
Moscow Regional Research Clinical Institute named after M.F. Vladimirsky/Neurology Department of Therapy Department
Moscow
Site status: Not listed — confirm with the team
Llc "Nizhmedklinika"
Nizhny Novgorod
Site status: Not listed — confirm with the team
Privolzhsky Research Medical University/Department of Neurology, Psychiatry and Narcology FDPO
Nizhny Novgorod
Site status: Not listed — confirm with the team
Orenburg Regional Clinical Psychiatric Hospital # 1/Children's psychiatric department
Orenburg
Site status: Not listed — confirm with the team
Perm State Medical University named after academician E.A. Wagner/Department of Neurology
Perm
Site status: Not listed — confirm with the team
LLC "Treatment and rehabilitation research center "PHOENIX"/Day hospital # 1
Rostov-on-Don
Site status: Not listed — confirm with the team
Ryazan State Medical University named after Acad. I.P. Pavlov/Department of Children's Diseases with a course of hospital pediatrics
Ryazan
Site status: Not listed — confirm with the team
National Medical Research Center for Psychiatry and Neurology named after V.M. Bekhterev
Saint Petersburg
Site status: Not listed — confirm with the team
Llc "Doctrina"
Saint Petersburg
Site status: Not listed — confirm with the team
Institute of the Human Brain named after N.P. Bekhtereva
Saint Petersburg
Site status: Not listed — confirm with the team
LLC "DNA Research Center"
Saratov
Site status: Not listed — confirm with the team
Saratov State Medical University named after V.I. Razumovsky/Department of Neurology. named after K.N. Tretyakov
Saratov
Site status: Not listed — confirm with the team
City Clinical Hospital # 2 named after V.I. Razumovsky
Saratov
Site status: Not listed — confirm with the team
Saratov City Psychoneurological Dispensary
Saratov
Site status: Not listed — confirm with the team
Smolensk Regional Clinical Hospital/Children's neurological department
Smolensk
Site status: Not listed — confirm with the team
Smolensk Regional Clinical Hospital/Pediatric neurological department
Children's City Clinical Hospital of Ulyanovsk city
Ulyanovsk
Site status: Not listed — confirm with the team
Yaroslavl State Medical University/Department of Polyclinic Pediatrics
Yaroslavl
Site status: Not listed — confirm with the team
Sverdlovsk Regional Clinical Psychiatric Hospital/Pediatric and adolescent medical and diagnostic department
Yekaterinburg
Site status: Not listed — confirm with the team
LLC "European Medical Center "UMMC-Health"/Children's polyclinic in the main branch
Yekaterinburg
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Prospekta, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with adhd; age range: From 7 Years to 12 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Materia Medica Holding, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
